<DOC>
	<DOCNO>NCT01538160</DOCNO>
	<brief_summary>Lately investigator find patient severe factor XI deficiency inhibitor could undergo major surgery single low dose recombinant factor VIIa tranexamic agent . These result encourage u apply treatment clinical trial set patient severe factor XI deficiency undergo surgery instead blood product .</brief_summary>
	<brief_title>A Single Low Dose Recombinant Factor VIIa Patients With Severe Factor XI Deficiency Undergoing Surgery</brief_title>
	<detailed_description>Eligible patient severe factor XI deficiency agree participate study . The treatment apply patient require coronary artery bypass vascular surgery .</detailed_description>
	<mesh_term>Factor XI Deficiency</mesh_term>
	<criteria>patient severe factor XI deficiency give inform consent participate study patient atherosclerosis disease i.e . unstable angina pectoris recent stroke Patients require aortocoronary bypass vascular surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>recombinant factor VIIa</keyword>
	<keyword>factor XI deficiency</keyword>
</DOC>